Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 283, pseudogene (RN7SL283P) is a pseudogene related to the 7SL RNA, which itself is a structural RNA component of the signal recognition particle (SRP). The SRP is critical for targeting secretory and membrane proteins to the endoplasmic reticulum. Unlike the functional 7SL RNA genes, RN7SL pseudogenes are generally non-coding genomic sequences derived from reverse transcription and integration of 7SL RNA transcripts. These pseudogenes do not produce functional RNA or protein and do not play an active biological role[1][2][4][5][8]. The majority of 7SL-like sequences in the human genome, including RN7SL283P, are such pseudogenes and are not expressed or involved in therapeutic or biological pathways[1][4][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 283, pseudogene (RN7SL283P).